| Nusrat Fatima Pathan, MD | |
|
6308 Central Ave, Aberdeen, NJ 07747-5506 | |
| (203) 512-6259 | |
| Not Available |
| Full Name | Nusrat Fatima Pathan |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 27 Years |
| Location | 6308 Central Ave, Aberdeen, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083947741 | NPI | - | NPPES |
| 0214884 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 47227 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Danbury Hospital | Danbury, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nuvance Health Medical Practice Ct Inc | 4789597691 | 648 |
News Archive
Today, at the 52nd annual New Clinical Drug Evaluation Unit (NCDEU) Conference in Arizona, Ian Cook, M.D., Professor of Psychiatry at the University of California, Los Angeles (UCLA) and a Senior Medical Advisor to NeuroSigma, Inc., presented the results from the first 6-subject cohort of a 10-subject Phase I open-label clinical trial studying the effects of external trigeminal nerve stimulation (eTNS) on Post-Traumatic Stress Disorder (PTSD) and depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy.
QIAGEN today announced that it has entered into an agreement with the Institute for Product Quality (ifp), pursuant to which QIAGEN has acquired all rights to 70 molecular food safety tests developed by the Berlin-based specialized laboratory center for food analysis.
Men often tolerate stress urinary incontinence for more than two years before seeking medical help - and one-third put up with it for more than five years, making it important for doctors to check for this problem, a new study from UT Southwestern researchers advises.
The Wall Street Journal: Medicare officials have suspended the Aetna insurance company from enrolling new members for "its Medicare Advantage and Medicare prescription-drug plans because the insurer didn't comply with rules about changing drug-plan designs, the government said." The sanctions come after the government says the Connecticut-based insurance company did not "meet requirements to make sure seniors could continue on their medications during changes to the Aetna plans in 2009 and those offered this year."
› Verified 3 days ago
| Entity Name | Nuvance Health Medical Practice Ct Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407898117 PECOS PAC ID: 4789597691 Enrollment ID: O20031205000130 |
News Archive
Today, at the 52nd annual New Clinical Drug Evaluation Unit (NCDEU) Conference in Arizona, Ian Cook, M.D., Professor of Psychiatry at the University of California, Los Angeles (UCLA) and a Senior Medical Advisor to NeuroSigma, Inc., presented the results from the first 6-subject cohort of a 10-subject Phase I open-label clinical trial studying the effects of external trigeminal nerve stimulation (eTNS) on Post-Traumatic Stress Disorder (PTSD) and depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy.
QIAGEN today announced that it has entered into an agreement with the Institute for Product Quality (ifp), pursuant to which QIAGEN has acquired all rights to 70 molecular food safety tests developed by the Berlin-based specialized laboratory center for food analysis.
Men often tolerate stress urinary incontinence for more than two years before seeking medical help - and one-third put up with it for more than five years, making it important for doctors to check for this problem, a new study from UT Southwestern researchers advises.
The Wall Street Journal: Medicare officials have suspended the Aetna insurance company from enrolling new members for "its Medicare Advantage and Medicare prescription-drug plans because the insurer didn't comply with rules about changing drug-plan designs, the government said." The sanctions come after the government says the Connecticut-based insurance company did not "meet requirements to make sure seniors could continue on their medications during changes to the Aetna plans in 2009 and those offered this year."
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nusrat Fatima Pathan, MD 27 Ashley Ct, Danbury, CT 06810-7270 Ph: (203) 512-6259 | Nusrat Fatima Pathan, MD 6308 Central Ave, Aberdeen, NJ 07747-5506 Ph: (203) 512-6259 |
News Archive
Today, at the 52nd annual New Clinical Drug Evaluation Unit (NCDEU) Conference in Arizona, Ian Cook, M.D., Professor of Psychiatry at the University of California, Los Angeles (UCLA) and a Senior Medical Advisor to NeuroSigma, Inc., presented the results from the first 6-subject cohort of a 10-subject Phase I open-label clinical trial studying the effects of external trigeminal nerve stimulation (eTNS) on Post-Traumatic Stress Disorder (PTSD) and depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy.
QIAGEN today announced that it has entered into an agreement with the Institute for Product Quality (ifp), pursuant to which QIAGEN has acquired all rights to 70 molecular food safety tests developed by the Berlin-based specialized laboratory center for food analysis.
Men often tolerate stress urinary incontinence for more than two years before seeking medical help - and one-third put up with it for more than five years, making it important for doctors to check for this problem, a new study from UT Southwestern researchers advises.
The Wall Street Journal: Medicare officials have suspended the Aetna insurance company from enrolling new members for "its Medicare Advantage and Medicare prescription-drug plans because the insurer didn't comply with rules about changing drug-plan designs, the government said." The sanctions come after the government says the Connecticut-based insurance company did not "meet requirements to make sure seniors could continue on their medications during changes to the Aetna plans in 2009 and those offered this year."
› Verified 3 days ago